Categories: Technology

Brain stimulation startup founder talks tackling the opioid crisis while navigating Y-Combinator (Podcast Episode)

Mental health and addiction have been longstanding issues across societies around the world. However, in our modern society, as stigma subsides around these issues, conversations and solutions have arisen. 

In today’s episode, we speak with Adrien Châtillon, CEO & Founder of Actipulse Neuroscience, a neuro-tech company specialized in the research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders, to get a better understanding of how their company’s technology stands to advance mental health and addiction treatment. 

Listen to this podcast on SpotifyAnchorApple PodcastsBreakerGoogle PodcastsStitcherOvercastListen NotesPodBean, and Radio Public.

To kick off the show, Châtillon shares the backstory of the two previous startups he founded before Actipulse. The first, a Slack for students, and the second, a French movie startup. 

He also discusses the company’s goal to bring this technology from a hospital setting to an at-home setting, to make it more affordable, and how they plan to do this.

Châtillon also highlights how their technology works and how it can help treat depression, smoking addiction and anxiety. Alongside how they intend to use it to slow down Parkison’s and Alzheimer’s.

Additionally, he talks about a recent study conducted by the company that saw 9 out of 10 subjects with smoking addiction stop smoking after treatment using its technology. 

Châtillon explains how they are targeting the dopamine mechanisms in the brain, and an upcoming second trial, which is currently underway, to help tackle opioid addiction. 

Finally, on the topic of addiction, Châtillon shares whether or not this technology might stand to tackle behavioral addictions such as gambling.

And before we wrap up the show, Châtillon shares what it has been like to go through the Y Combinator program and advice for other startups and entrepreneurs that want to be selected for the program.

Disclosure: This episode includes a client of an Espacio portfolio company

Sam Brake Guia

Sam is an energetic and passionate writer/presenter, always looking for the next adventure. In August 2016 he donated all of his possessions to charity, quit his job, and left the UK. Since then he has been on the road travelling through North, Central and South America searching for new adventures and amazing stories.

Recent Posts

Decision Points: The “Tiger” Methodology for Decisive Action

At some point in the last 10 years, I started viewing Colonel John Boyd as…

3 days ago

Architecting Zero-Click AI Eval Pipelines

When I started designing an AI Evaluation pipeline/framework at my organization, I had no idea…

3 days ago

Tech executive Bob Reisenweber named Director of Operations at Source Meridian

This week software firm Source Meridian announced that Bob Reisenweber was named its new Director…

6 days ago

Beyond big tech: These 26 leaders are writing the next chapter of AI 

The early wave of AI disruption focused on the tech's ability to work as a…

6 days ago

DARPA Generative Optogenetics (GO) program gathers biosecurity, regulatory advisers for commercializing programmable biology tech

DARPA GO could be used for human performance enhancement & bioengineered super-soldiers, along with the…

6 days ago

OpenAI submitted models to the hardest math test yet for AI

OpenAI published its proof attempts on February 14 for First Proof, a challenge put together…

1 week ago